Lack of prognostic value of p53 protein expression in node-negative breast cancer

Tumori

Volumn 83, Issue 3, 1997, Pages 669-672

  Bianchi, Simonetta ^a   Calzolari, Anna ^a   Vezzosi, Vania ^a   Zampi, Giancarlo ^a   Cardona, Gaetano ^b   Cataliotti, Luigi ^a   Bonardi, Rita ^c   Ciatto, Stefano ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Camerata Hospital   (Italy)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

breast cancer; immunohistochemistry; p53; prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS;

EID: 0030739185     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300309     Document Type: Article

References (25)

1. Allred D.C., Clark G.M., Elledge R., Fuqua S.A.W, Brown R.W., Chamness G.C.: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst., 85: 200-206, 1993.
2. Black M.M., Speer F.D.: Nuclear structure in cancer tissues. Surg. Gynecol. Obstet., 105: 97-102, 1957.
3. Bosari S., Lee A.K.C., Viale G., Heatley G.J., Coggi G.: Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long term follow-up. Virchows Archiv A. Pathol. Anat. 421: 291-293, 1992.
4. Cattoretti G., Rilke F., Andreola S., D'Amato L., D'Elia D.: p53 expression in breast cancer. Int. J. Cancer, 41: 178-83, 1988.
5. Ciatto S., Cecchini S., Grazzini G., Iossa A., Bartoli D., Rasponi A.: Tumor size and prognosis of breast cancer with negative axillary nodes. Neoplasma, 37: 179-84, 1990.
6. Cox D.R.: Regression models and life tables. J. Royal Stat. Soc., 34: 187-202, 1972.
7. Davidoff A.M., Herndon J.E., Glover N.S., Kerns B.M., Pence J.C., Iglehart J.D.: Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery, 110: 259-64, 1991.
8. Fisher F.R., Redmond C., Fisher B.: Histologic grading of breast cancer. Pathol. Annu., 15: 239-251, 1980.
9. Fisher C.J., Gillett C.E., Vojtesek B., Barnes D.M., Millis R.R.: Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Br. J. Cancer, 69: 26-31, 1994.
10. Hanzal E., Gitsch G., Kohlberger P., Dadak C.H., Miechowiecka N., Breitenecker G.: Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Research, 12: 2323-2330, 1992.
11. Hurlimann J.: Prognostic value of p53 protein expression in breast carcinoma. Path. Res. Pract., 189: 996-1003, 1993.
12. Hurlimann J., Chaubert P., Benhattar J.: p53 gene alterations and p53 protein accumulation in infiltrating duct breast carcinomas: correlations between immunohistochemical and molecular biology techniques. Modern Pathology, 7: 423-428, 1994.
13. International Union Against Cancer. TNM Classification of malignant tumors. 4th ed. Berlin: Springer Verlag, 1987.
14. Isola J., Visakorpi T., Holli K., Kallioniemi O.P.: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J. Natl. Cancer Inst., 84: 1109-1114, 1992.
15. Jacquemier J., Moles J.P., Penault-Llorca P., Adelaide J., Torrente M., Viens P.: p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br. J. Cancer, 69: 846-852, 1994.
16. Kaplan E.L., Meier P.: Non parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
17. Lamb P., Crawford L.V.: Characterisation of the human p53 gene. Mol. Cell. Biol., 6: 1379-1385, 1986.
18. McGuire W.L., Tandon A.K., Allred D.C., Chamness G.C., Clark G.M.: How to use prognostic factors in axillary node-negative breast cancer patients. J. Natl. Cancer Inst., 82: 1006-1013, 1990.
19. National Cancer Institute. Proceedings of the NIH Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. NCI Monograph, 1986.
20. Ostrowski J.L., Sawan A., Henry L., Wright C., Henry J.A., Hennessy C.: p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J. Pathol., 164: 75-81, 1991.
21. Silvestrini R., Benini E., Daidone M.G., Veneroni S., Boracchi P., Cappelletti V.: p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J. Natl. Cancer Inst., 85: 965-970, 1993.
22. Stenmark-Askmalm M., Stal O., Olson K., Nordenskjold B.: P53 as a prognostic factor in stage I breast cancer. Br. J. Cancer, 72: 715-719, 1995.
23. Thor A.D., Moore D.H., Edgerton S.M., Kawasaki E.S., Reihsaus E., Lynch H.T.: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer. J. Natl. Cancer Inst., 84: 845-855, 1992.
24. Thorlacius S., Thorgilsson B., Bjornsson J., Tryggvadottir L., Børresen A.L., Ogmundsdottir H.M.: TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis. Eur. J. Cancer, 31: 1856-1861, 1995.
25. Visscher D.W., Sarker F.H., Wykes S., Kothari K., Macoska J., Crissman J.: Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast. Arch. Pathol. Lab. Med., 117: 973-976, 1993.